Overview
Mariko Ishibashi practices in Sendagi, Japan. Ms. Ishibashi is rated as an Advanced expert by MediFind in the treatment of Multiple Myeloma. Her top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), and Acute Tubular Necrosis.
Her clinical research consists of co-authoring 25 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 13 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Multiple MyelomaMs. Ishibashi isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Acute Tubular NecrosisMs. Ishibashi isExperienced. Learn about Acute Tubular Necrosis.
- Hashimoto ThyroiditisMs. Ishibashi isExperienced. Learn about Hashimoto Thyroiditis.
- HepatitisMs. Ishibashi isExperienced. Learn about Hepatitis.
- Hepatitis CMs. Ishibashi isExperienced. Learn about Hepatitis C.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myelodysplastic Syndrome (MDS)Ms. Ishibashi isExperienced. Learn about Myelodysplastic Syndrome (MDS).